100 related articles for article (PubMed ID: 27041399)
21. Bioactive compounds of Eriocaulon sieboldianum blocking proliferation and inducing apoptosis of HepG2 cells might be involved in Aurora kinase inhibition.
Fan Y; Lu H; Ma H; Feng F; Hu X; Zhang Q; Wang J; Xu Y; Zhao Q
Food Funct; 2015 Dec; 6(12):3746-59. PubMed ID: 26369427
[TBL] [Abstract][Full Text] [Related]
22. Design, Synthesis, and Biochemical Evaluation of New Triazole Derivatives as Aurora-A Kinase Inhibitors.
Abdullah O
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577149
[TBL] [Abstract][Full Text] [Related]
23. Ligand efficiency based approach for efficient virtual screening of compound libraries.
Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP
Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626
[TBL] [Abstract][Full Text] [Related]
24. Aurora kinase A inhibitors: promising agents in antitumoral therapy.
Malumbres M; Pérez de Castro I
Expert Opin Ther Targets; 2014 Dec; 18(12):1377-93. PubMed ID: 25200357
[TBL] [Abstract][Full Text] [Related]
25. The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Catania A; Moretti C; Mocini R; Carbotta G; Morrone S; Persechino S; Redler A; De Antoni E; D' Armiento M; Ulisse S
J Biol Regul Homeost Agents; 2013; 27(3):705-15. PubMed ID: 24152827
[TBL] [Abstract][Full Text] [Related]
26. General Ser/Thr Kinases Pharmacophore Approach for Selective Kinase Inhibitors Search as Exemplified by Design of Potent and Selective Aurora A Inhibitors.
Vasilevich NI; Aksenova EA; Kazyulkin DN; Afanasyev II
Chem Biol Drug Des; 2016 Jul; 88(1):54-65. PubMed ID: 26825399
[TBL] [Abstract][Full Text] [Related]
27. SAR156497, an exquisitely selective inhibitor of aurora kinases.
Carry JC; Clerc F; Minoux H; Schio L; Mauger J; Nair A; Parmantier E; Le Moigne R; Delorme C; Nicolas JP; Krick A; Abécassis PY; Crocq-Stuerga V; Pouzieux S; Delarbre L; Maignan S; Bertrand T; Bjergarde K; Ma N; Lachaud S; Guizani H; Lebel R; Doerflinger G; Monget S; Perron S; Gasse F; Angouillant-Boniface O; Filoche-Rommé B; Murer M; Gontier S; Prévost C; Monteiro ML; Combeau C
J Med Chem; 2015 Jan; 58(1):362-75. PubMed ID: 25369539
[TBL] [Abstract][Full Text] [Related]
28. Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Morrone S; Moretti C; Bononi M; Arlot-Bonnemains Y; D'Armiento M; Ulisse S
Endocr Relat Cancer; 2014 Oct; 21(5):797-811. PubMed ID: 25074669
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors.
Beniwal M; Jain N; Jain S; Aggarwal N
BMC Chem; 2022 Aug; 16(1):61. PubMed ID: 35978438
[TBL] [Abstract][Full Text] [Related]
30. Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases.
Shin SY; Yoon H; Hwang D; Ahn S; Kim DW; Koh D; Lee YH; Lim Y
Bioorg Med Chem; 2013 Nov; 21(22):7018-24. PubMed ID: 24095020
[TBL] [Abstract][Full Text] [Related]
31. 7-Chloroquinolinotriazoles: synthesis by the azide-alkyne cycloaddition click chemistry, antimalarial activity, cytotoxicity and SAR studies.
Pereira GR; Brandão GC; Arantes LM; de Oliveira HA; de Paula RC; do Nascimento MF; dos Santos FM; da Rocha RK; Lopes JC; de Oliveira AB
Eur J Med Chem; 2014 Feb; 73():295-309. PubMed ID: 24469080
[TBL] [Abstract][Full Text] [Related]
32. Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia.
Jagtap AD; Chang PT; Liu JR; Wang HC; Kondekar NB; Shen LJ; Tseng HW; Chen GS; Chern JW
Eur J Med Chem; 2014 Oct; 85():268-88. PubMed ID: 25089810
[TBL] [Abstract][Full Text] [Related]
33. Identification of 3,5,6-substituted indolin-2-one's inhibitors of Aurora B by development of a luminescent kinase assay.
Zhang L; Yang T; Xie X; Liu G
Bioorg Med Chem Lett; 2015 Aug; 25(15):2937-42. PubMed ID: 26048792
[TBL] [Abstract][Full Text] [Related]
34. A computational model for overcoming drug resistance using selective dual-inhibitors for aurora kinase A and its T217D variant.
Barakat KH; Huzil JT; Jordan KE; Evangelinos C; Houghton M; Tuszynski J
Mol Pharm; 2013 Dec; 10(12):4572-89. PubMed ID: 24094068
[TBL] [Abstract][Full Text] [Related]
35. Syntheses of 1,2,3-triazolyl salicylamides with inhibitory activity on lipopolysaccharide-induced nitric oxide production.
Yoon J; Cho L; Lee SK; Ryu JS
Bioorg Med Chem Lett; 2011 Apr; 21(7):1953-7. PubMed ID: 21377876
[TBL] [Abstract][Full Text] [Related]
36. New benzimidazoles and their antitumor effects with Aurora A kinase and KSP inhibitory activities.
Abd El-All AS; Magd-El-Din AA; Ragab FA; ElHefnawi M; Abdalla MM; Galal SA; El-Rashedy AA
Arch Pharm (Weinheim); 2015 Jul; 348(7):475-86. PubMed ID: 25900113
[TBL] [Abstract][Full Text] [Related]
37. LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cells.
Wang H; Li R; Li L; Ge Z; Zhou R; Li R
Biochem Biophys Res Commun; 2015 Feb; 458(1):201-7. PubMed ID: 25645017
[TBL] [Abstract][Full Text] [Related]
38. Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors.
Ji Z; Dai Y; Abad-Zapatero C; Albert DH; Bouska JJ; Glaser KB; Marcotte PA; Soni NB; Magoc TJ; Stewart KD; Wei RQ; Davidsen SK; Michaelides MR
Bioorg Med Chem Lett; 2012 Jul; 22(14):4528-31. PubMed ID: 22727637
[TBL] [Abstract][Full Text] [Related]
39. Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity.
Coumar MS; Leou JS; Shukla P; Wu JS; Dixit AK; Lin WH; Chang CY; Lien TW; Tan UK; Chen CH; Hsu JT; Chao YS; Wu SY; Hsieh HP
J Med Chem; 2009 Feb; 52(4):1050-62. PubMed ID: 19140666
[TBL] [Abstract][Full Text] [Related]
40. Exploring the functional space of thiiranes as gelatinase inhibitors using click chemistry.
Testero SA; Llarrull LI; Fisher JF; Chang M; Mobashery S
ARKIVOC; 2011; 2011(7):221-226. PubMed ID: 32774191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
